PRKCA and metabolic dysfunction-associated steatotic liver disease: Subsequently, the enhanced PKC-α activation stimulated FA and TG synthesis and FA uptake and modulated their metabolism in hepatocytes, leading to excessive accumulation of intrahepatic lipids and promoting the progression of NAFLD.